A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pemetrexed|DRUG: gemcitabine
Sponsor: Eli Lilly and Company